Pages

Tuesday, August 19, 2025

 

Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market
Copycat weight loss drugs were supposed to be pulled from the market, but pharmacies have found a loophole.

No comments:

Post a Comment